Table 2

CK7/20 phenotype and CDX2 expression in our studied groups

Colorectal AdenoCa

(n = 118)

Gastric AdenoCa

(n = 59)

Pancreatic AdenoCa

(n = 32)




CDX2+

CDX2-

CDX2+

CDX2-

CDX2+

CDX2-


CK7-/CK20+

74 (62%)

1 (1%)

3 (5%)

0 (0%)

0 (0%)

0 (0%)

CK7+/CK20+

22 (19%)

2 (2%)

21 (36%)

7 (12%)

2 (6%)

5 (16%)

CK7+/CK20-

2 (2%)

0 (0%)

8 (14%)

11 (19%)

3 (9%)

21 (66%)

CK7-/CK20-

16 (14%)

1 (1%)

4 (7%)

5 (9%)

0 (0%)

1 (3%)


Bayrak et al. Diagnostic Pathology 2012 7:9   doi:10.1186/1746-1596-7-9

Open Data